📇 Rhumatologue · PARIS · (75) · Libéral
Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
2 raisons identifiées
Auteur de référence en rhumatologie
37 articles scientifiques publiés — un praticien à la pointe de la recherche
Délais de RDV courts dans la région
336.2 rhumatos / 100 000 hab. — département bien doté
✨ Génération du profil synthétique IA en cours…
CABINET DU DR MICHELLE PEREZ
RESIDENCE BELLEVILLE BATIMENT 10 5 RUE DE BELLEVILLE, 75019 PARIS
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Frontiers in pediatrics · 2021
Background: Following the spread of the coronavirus disease 2019 (COVID-19) pandemic a new disease entity emerged, defined as Pediatric Inflammatory Multisystem Syndrome temporally associated with COVID-19 (PIMS-TS), or Multisystem Inflammatory Syndrome in Children (MIS-C). In the absence of trials, evidence for treatment remains scarce.Purpose: To develop best practice recommendations for the diagnosis and treatment of children with PIMS-TS in Switzerland. It is acknowledged that the field is changing rapidly, and regular revisions in the coming months are pre-planned as evidence is increasing.Methods: Consensus guidelines for best practice were established by a multidisciplinary group of Swiss pediatric clinicians with expertise in intensive care, immunology/rheumatology, infectious diseases, hematology, and cardiology. Subsequent to literature review, four working groups established draft recommendations which were subsequently adapted in a modified Delphi process. Recommendations had to reach >80% agreement for acceptance.Results: The group achieved agreement on 26 recommendations, which specify diagnostic approaches and interventions across anti-inflammatory, anti-infectious, and support therapies, and follow-up for children with suspected PIMS-TS. A management algorithm was derived to guide treatment depending on the phenotype of presentation, categorized into PIMS-TS with (a) shock, (b) Kawasaki-disease like, and (c) undifferentiated inflammatory presentation.Conclusion: Available literature on PIMS-TS is limited to retrospective or prospective observational studies. Informed by these cohort studies and indirect evidence from other inflammatory conditions in children and adults, as well as guidelines from international health authorities, the Swiss PIMS-TS recommendations represent best practice guidelines based on currently available knowledge to standardize treatment of children with suspected PIMS-TS. Given the absence of high-grade evidence, regular updates of the recommendations will be warranted, and participation of patients in trials should be encouraged.
Annals of the rheumatic diseases · 2023
The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons · 2021
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
JBMR plus · 2026 · Journal Article
Perez MO, Sales LP, Jorgetti V, Caparbo VF, et al.
Cureus · 2025 · Case Reports
Reid BE, Perez M, Abd Elmageed Z, DiGiuseppe S, et al.
Scientific reports · 2025 · Journal Article
Pérez MM, Rissech C, Porta-Vilaró M, Reguera C, et al.
The Journal of bone and joint surgery. American volume · 2025 · Journal Article
Pekas DR, Perez M, Yu-Shan AA, Bailey C, et al.
Cureus · 2025 · Case Reports
Tole MC, Perez MV, Mekonen YF, Bermudez M, et al.
Frontiers in oncology · 2024 · Journal Article
Yan H, Gonzalo-Encabo P, Wilson RL, Christopher CN, et al.
Disease models & mechanisms · 2024 · Journal Article
Akinyele O, Munir A, Johnson MA, Perez MS, et al.
Journal of medicinal chemistry · 2024 · Journal Article
Tyhonas JS, Arnold LD, Cox JM, Franovic A, et al.
Reumatologia clinica · 2024 · Journal Article
Otón T, Messina OD, Fernández Ávila DG, Robles San Román M, et al.
Annals of the rheumatic diseases · 2023 · Journal Article
Collins JA, Kim CJ, Coleman A, Little A, et al.
Frontiers in immunology · 2023 · Journal Article
Sales LP, Hounkpe BW, Perez MO, Caparbo VF, et al.
Transplant infectious disease : an official journal of the Transplantation Society · 2023 · Journal Article
Fernandez AA, Simkins J, Anjan S, Abbo L, et al.
International journal of rheumatic diseases · 2022 · Journal Article
Figueiredo CP, Perez MO, Sales LP, Domiciano DS, et al.
Arthritis & rheumatology (Hoboken, N.J.) · 2022 · Journal Article
Perez MO, Figueiredo CP, Sales LP, Medeiros-Ribeiro AC, et al.
Therapeutic advances in musculoskeletal disease · 2021 · Journal Article
Coste J, Medkour T, Maigne JY, Pérez M, et al.
Journal of medical ultrasound · 2021 · Case Reports
Sahoo RK, Galluccio F, Chang KV, Perez MF
International journal of rheumatic diseases · 2021 · Journal Article
Figueiredo CP, Perez MO, Sales LP, Caparbo VF, et al.
Clinical rheumatology · 2021 · Journal Article
Furlam PL, Perez MO, Franco AS, Caparbo VF, et al.
Reumatologia clinica · 2021 · Practice Guideline
Cardiel MH, Carrillo S, Pérez M, Andrade L, et al.
International journal of rheumatic diseases · 2021 · Journal Article
Molina Collada J, Castrejón I, Pérez M, Nieto-González JC, et al.
Modern rheumatology · 2021 · Journal Article
Figueiredo CP, Perez MO, Sales LP, Schett G, et al.
BMC musculoskeletal disorders · 2021 · Journal Article
Figueiredo CP, Perez MO, Sales LP, Medeiros AC, et al.
The journal of allergy and clinical immunology. Global · 2025 · Journal Article
Rezwan T, Perez M, Jacobs S, Shafik J, et al.
Journal of pediatric hematology/oncology · 2023 · Review
Watts S, Diaz M, Teller C, Hamby T, et al.
Frontiers in pediatrics · 2021 · Journal Article
Schlapbach LJ, Andre MC, Grazioli S, Schöbi N, et al.
Frontiers in immunology · 2024 · Journal Article
Hounkpe BW, Sales LP, Ribeiro SCR, Perez MO, et al.
Seminars in arthritis and rheumatism · 2023 · Journal Article
Ribeiro SCCR, Sales LP, Fernandes AL, Perez MO, et al.
JMIR research protocols · 2024 · Clinical Trial Protocol
Normann AJ, Mo CC, Wilson RL, Perez M, et al.
Therapeutic advances in musculoskeletal disease · 2021 · Journal Article
Coste J, Medkour T, Maigne JY, Pérez M, et al.
Reumatologia clinica · 2023 · Case Reports
Pérez ML, Laso RV, Velasco-Rodríguez D, Martín-Herrero S, et al.
Microbial pathogenesis · 2020 · Journal Article
Múnera M, Farak J, Pérez M, Rojas J, et al.
Therapeutic advances in musculoskeletal disease · 2023 · Case Reports
Lam KHS, Wu YT, Reeves KD, Hadzic A, et al.
Archives of osteoporosis · 2021 · Journal Article
Pereira RMR, Perez MO, Paula AP, Moreira C, et al.
Journal of clinical medicine · 2023 · Journal Article
Otobo TM, Tolend M, Meyers AB, Sudol-Szopinska I, et al.
The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons · 2021 · Journal Article
Miranda MAM, Martins C, Cortegana IM, Campos G, et al.
The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons · 2021 · Journal Article
Miranda MAM, Martins C, Cortegana IM, Campos G, et al.
Ultrasound in medicine & biology · 2020 · Journal Article
Pérez M, Zuccaro J, Mohanta A, Tijerin M, et al.
The Journal of pediatrics · 2021 · Journal Article
Perez MM, Medar S, Quigley L, Clark BC
✨ Profil synthétique
IA · 25/05/2026MME Michelle PEREZ est une rhumatologue libérale exerçant à Paris. Ses publications sur PubMed révèlent une expertise dans le domaine de la pédiatrie, notamment dans le traitement de l'arthrite juvénile et du lupus. Elle a également participé à des essais cliniques et des études de cas.
Expertises présumées
Synthèse automatique à partir des sources publiques (HAL, OpenAlex, theses.fr, ClinicalTrials.gov, FAI²R, ANS). Pas une évaluation clinique. Le médecin peut corriger via son compte.